CLINICAL-FEATURES AND DURATION OF TRAVELERS DIARRHEA IN RELATION TO ITS ETIOLOGY

Authors
Citation
L. Mattila, CLINICAL-FEATURES AND DURATION OF TRAVELERS DIARRHEA IN RELATION TO ITS ETIOLOGY, Clinical infectious diseases, 19(4), 1994, pp. 728-734
Citations number
46
Categorie Soggetti
Microbiology,Immunology,"Infectious Diseases
ISSN journal
10584838
Volume
19
Issue
4
Year of publication
1994
Pages
728 - 734
Database
ISI
SICI code
1058-4838(1994)19:4<728:CADOTD>2.0.ZU;2-D
Abstract
Clinical features of traveler's diarrhea (TD) were studied among 126 a dult Finnish tourists who developed this illness during or shortly aft er a visit to Morocco. Enteric pathogens were identified in 76 (60%) o f cases, whereas the etiology remained unidentified in 50 cases (40%). Patients with an identified pathogen did not differ from those with T D of unknown etiology in terms of the time of onset of illness or the median frequency of unformed stools in the first 24 hours. In contrast , the median frequency of unformed stools between 24 and 48 hours (i.e ., on the second day) was 1.0 among patients with no pathogen and 2.0 among those with enteric pathogens identified (P < .001). A similar di fference was evident on the third day (1.0 vs. 2.5). Moreover, a lower proportion of patients with no pathogen identified had watery stools (28% vs. 55%). The durations of diarrhea and concomitant symptoms were significantly shorter and the recovery from TD was significantly quic ker among the patients without an identified pathogen. Patients with o ne or more invasive pathogens had disease that was clearly more severe than that of patients with no pathogen identified; the difference in severity of disease was less marked for patients with invasive vs. non invasive pathogens. Individuals with diarrhea due to Campylobacter spe cies tended to have the most severe disease, whereas diarrhea caused b y enterotoxigenic Escherichia coli seemed milder than that caused by o ther agents. Unfortunately, the clinician has only a limited opportuni ty to predict the etiology of TD and thus to assess the need for antim icrobial therapy at the onset of disease.